Cardiorespiratory fitness measured with cardiopulmonary exercise testing and mortality in patients with cardiovascular disease: A systematic review and meta-analysis

•High cardiorespiratory fitness (CRF) in patients with cardiovascular disease (CVD) is associated with 58% lower all-cause mortality risk and 73% lower cardiovascular mortality risk compared to unfit counterparts.•Each 1 metabolic equivalent (1-MET) increase in CRF is associated with a 19% lower CVD...

Full description

Saved in:
Bibliographic Details
Published inJournal of sport and health science Vol. 10; no. 6; pp. 609 - 619
Main Authors Ezzatvar, Yasmin, Izquierdo, Mikel, Núñez, Julio, Calatayud, Joaquín, Ramírez-Vélez, Robinson, García-Hermoso, Antonio
Format Journal Article
LanguageEnglish
Published China Elsevier B.V 01.12.2021
CIBER in Cardiovascular Diseases (CIBERCV),Madrid 28029,Spain%Navarrabiomed,Navarra Hospital Complex (CHN),Public University of Navarra (UPNA),Navarra Medical Research Institute (IdiSNA),Pamplona 31008,Spain
CIBER of Frailty and Healthy Aging (CIBERFES),Instituto de Salud Carlos Ⅲ,Madrid 28029,Spain%Department of Cardiology,Valencia University Hospital Biomedical Research Institute (INCLIVA),Valencia 46010,Spain
Sciences of Physical Activity,Sports and Health School University of Santiago of Chile (USACH),Santiago 71783-5,Chile
Exercise Intervention for Health Research Group (EXINH-RG),Department of Physiotherapy,Universitat de València,Valencia 46010,Spain%Navarrabiomed,Navarra Hospital Complex (CHN),Public University of Navarra (UPNA),Navarra Medical Research Institute (IdiSNA),Pamplona 31008,Spain
CIBER of Frailty and Healthy Aging (CIBERFES),Instituto de Salud Carlos Ⅲ,Madrid 28029,Spain
Shanghai University of Sport
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•High cardiorespiratory fitness (CRF) in patients with cardiovascular disease (CVD) is associated with 58% lower all-cause mortality risk and 73% lower cardiovascular mortality risk compared to unfit counterparts.•Each 1 metabolic equivalent (1-MET) increase in CRF is associated with a 19% lower CVD mortality risk among patients with CVD.•Coronary artery disease patients with high CRF have a 68% lower all-cause mortality risk than their unfit counterparts.•Each 1-MET increase in CRF is associated with a 17% lower all-cause mortality risk among patients with coronary artery disease.•No significant associations were found between increments of 1-MET and lower mortality risk among heart failure patients. Cardiorespiratory fitness (CRF) is inversely associated with mortality in apparently healthy subjects and in some clinical populations, but evidence for the association between CRF and all-cause and/or cardiovascular disease (CVD) mortality in patients with established CVD is lacking. This study aimed to quantify this association. We searched for prospective cohort studies that measured CRF with cardiopulmonary exercise testing in patients with CVD and that examined all-cause and CVD mortality with at least 6 months of follow-up. Pooled hazard ratios (HRs) were calculated using random-effect inverse-variance analyses. Data were obtained from 21 studies and included 159,352 patients diagnosed with CVD (38.1% female). Pooled HRs for all-cause and CVD mortality comparing the highest vs. lowest category of CRF were 0.42 (95% confidence interval (95%CI): 0.28–0.61) and 0.27 (95%CI: 0.16–0.48), respectively. Pooled HRs per 1 metabolic equivalent (1-MET) increment were significant for all-cause mortality (HR = 0.81; 95%CI: 0.74–0.88) but not for CVD mortality (HR = 0.75; 95%CI: 0.48–1.18). Coronary artery disease patients with high CRF had a lower risk of all-cause mortality (HR = 0.32; 95%CI: 0.26–0.41) than did their unfit counterparts. Each 1-MET increase was associated with lower all-cause mortality risk among coronary artery disease patients (HR = 0.83; 95%CI: 0.76–0.91) but not lower among those with heart failure (HR = 0.69; 95%CI: 0.36–1.32). A better CRF was associated with lower risk of all-cause mortality and CVD. This study supports the use of CRF as a powerful predictor of mortality in this population. [Display omitted]
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
ISSN:2095-2546
2213-2961
2213-2961
DOI:10.1016/j.jshs.2021.06.004